The CDC updates the vaccine price list to include new meningococcal B and HPV vaccines.

Practices should use the Private Sector Cost/Dose column as a guideline when negotiating payer contracts.  The AAP business case for administering vaccines recommends negotiating reimbursement for the cost of the vaccine that floats 17%-28% above the CDC private sector list price.  The floating rate helps ensure your reimbursement rates adjust when catalog prices are increased by the manufacturers and the additional percentage accounts for the indirect costs of ordering, storing and managing vaccines.